This entry was submitted in error by DiaMedica Therapeutics, Inc. and was not authorized by any of the trial Investigators or study sponsor (Stellenbosch University). The clinical trial, DM199 for Pregnancy Complications, was prospectively registered with the Pan African Clinical Trials Registry (PACTR202404895013782), in accordance with ICMJE and WHO requirements. This listing serves as the primary and authoritative registration record for this investigator-initiated study.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
OTHER
Masking
NONE
DM199 is a synthetic form of rhKLK1
Incidence of treatment adverse events
Time frame: Until 6 weeks after the due date
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.